IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis.

Yang ShumeiLi YiMeng HuanyuLi ZhibinJin WanlinXu LiqunHuan Yang

Published in: European journal of clinical pharmacology (2019)

Myasthenia gravis patients with the rs2069762 variant, rs2069762 G/T and G/G genotype, and TAGG haplotype for IL-2 tended to respond poorly to Tac treatment.

Keyphrases

myasthenia gravis
combination therapy
smoking cessation